James is a partner and corporate lawyer who specialises in advising on complex cross-border business transactions, including M&A, IPOs, joint ventures, structured equity investments, venture capital and growth capital financing rounds.
James acts for clients all the way through the life cycle, including founders, growth companies, VC investors, institutions and listed companies (both LSE and Nasdaq), primarily in the technology and structured investment sectors.
James joined Taylor Wessing as a trainee in 2010.
Advised Allocate Software plc on its £109 million recommended takeover by Hg Capital.
Various pre-IPO funding rounds and IPOs, including for FDM Group, Attraqt Group, Creo Medical, Sphere Medical, Rezolve, Tritax Big Box and Boku.
Advising founders, companies and institutional investors on numerous venture and growth stage funding rounds, in the tech and life science sectors.
Advised Accel-KKR and the founders on the disposal of One.com to Cinven Private Equity.
Hilton Food Group plc on its class 1 acquisition of Icelandic SeaChill, funded by a underwritten placing and senior debt package.
The new space race – outlook and opportunities in 2024
James Homan and Timo Stellpflug look at the investment landscape for 'New Space' technologies.
作者 James Homan 以及 Timo Stellpflug
2 / 5 观点
作者 Dr. Amir-Said Ghassabeh 以及 Dr. David Klein, LL.M. (Univ. of Washington), CIPP/E
作者